Close Menu

NEW YORK (360Dx) – Two Pore Guys is looking to expand its presence in the diagnostics space with the development of a nanopore platform for use in doctors' clinics to test for autoimmune conditions and infectious diseases.

A clinical assay for these applications could take about three years before it hits the market, but the firm anticipates eventually releasing a sensitive test for type 1 diabetes that would cost far less than a laboratory-based test, Two Pore Guys Cofounder and Chief Scientific Officer Trevor Morin said in an interview.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.
Sep
16
Sponsored by
ArcherDX

This webinar will discuss a next-generation sequencing approach for detecting genomic mutations in hematologic maglignancies.

Oct
24

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.